HO-1 and VGEF gene expression in human arteries with advanced atherosclerosis

Clinical Biochemistry

Volumn 39, Issue 11, 2006, Pages 1057-1062

  Morsi, Wael G ^a   Shaker, Olfat G ^b   Ismail, Emad F ^a   Ahmed, Hanan H ^b   El Serafi, Taher I ^a   Maklady, Fathy A ^a   Abdel Aziz, Mohamed T ^b   El Asmar, Mohammed F ^c   Atta, Hussein M ^d  

^a Suez Canal University Faculty of Medicine   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c Ain Shams University   (Egypt)

^d Minia University   (Egypt)

Author keywords

Angiogenesis; Atherosclerosis; HO 1; Revascularization; RT PCR; VEGF

Indexed keywords

BILIRUBIN; HEME OXYGENASE 1; VASCULOTROPIN;

ADULT; ARTERY; ARTICLE; ATHEROSCLEROSIS; CELL ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT;

ADULT; AGED; ATHEROSCLEROSIS; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION; HEME OXYGENASE-1; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33750962702     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.08.003     Document Type: Article

References (42)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
2. Steinberg D. Antioxidants and atherosclerosis. A current assessment. Circulation 84 (1991) 1420-1425
3. Hoekstra K.A., Godin D.V., and Cheng K.M. Protective role of heme oxygenase in the blood vessel wall during atherogenesis. Biochem. Cell. Biol. 82 (2004) 351-359
4. Juan S.-H., Lee T.-S., Tseng K.-W., Liou J.-Y., Shyue S.-K., Wu K.K., et al. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104 (2001) 1519-1525
5. Ameriso S.F., Villamil A.R., Zedda C., Parodi J.C., Garrido S., Sarchi M.I., et al. Heme oxygenase-1 is expressed in carotid atherosclerotic plaques infected by Helicobacter pylori and is more prevalent in asymptomatic subjects. Stroke 36 (2005) 1896-1900
6. Ishikawa K., Navab M., and Leitinger N. Induction of heme oxygenase-1 inhibits monocyte transmigration induced by mildly oxidized LDL. J. Clin. Invest. 100 (1997) 1209-1216
7. Wang L.J., Lee T.S., and Lee F.Y. Expression of heme-oxygenase-1 in atherosclerotic lesions. Am. J. Pathol. 152 (1998) 711-720
8. Yet S.-F., Layne M.D., Liu X., Chen Y.-H., Ith B., Sibinga N.E.S., et al. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J. 17 (2003) 1759-1761
9. Abraham N.G., Drummond G.S., and Lutton J.D. The biological significance and physiological role of heme oxygenase. Cell. Physiol. Biochem. 6 (1996) 129-138
10. Ishikawa K. Heme oxygenase-1 against vascular insufficiency: roles of atherosclerotic disorders. Curr. Pharm. Des. 30 (2003) 2489-2497
11. Durante W., Kroll M.H., and Christodoulides N. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ. Res. 80 (1997) 557-564
12. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 18 (1997) 4-25
13. Makin A.J., Chung N.A.Y., Silverman S.H., and Lip G.Y.H. Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis?. Clin. Sci. 104 (2003) 397-404
14. Matsui K., Yoshioka T., Murakami Y., Takahashi M., Shimada K., and Ikeda U. Serum concentrations of vascular endothelial growth factor and monocyte-colony stimulating factor in peripheral arterial disease. Circ. J. 67 (2003) 660-662
15. Roller R.E., Renner W., Dorr A., Pilger E., and Schnedl W.J. Oxidative stress and increase of vascular endothelial growth factor in plasma of patients with peripheral arterial occlusive disease. Thromb. Haemost. 85 (2001) 368
16. Nakajima K., Tabata S., Yamashita T., Kusuhara M., Arakawa K., Ohmori R., et al. Plasma vascular endothelial growth factor level is elevated in patients with multivessel coronary artery disease. Clin. Cardiol. 27 (2004) 281-286
17. Lim H.S., Lip G.Y., and Blann A.D. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. Atherosclerosis 180 (2005) 113-118
18. Alber H.F., Frick M., and Dulak J. Vascular endothelial growth factor (VEGF) plasma concentrations in coronary artery disease. Heart 91 (2005) 365-366
19. Khurana R., Simons M., Martin J.F., and Zachary I.C. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 112 (2005) 1813-1824
20. Cucina A., Borrelli V., Randone B., Coluccia P., Sapienza P., and Cavallaro A. Vascular endothelial growth factor increases the migration and proliferation of smooth muscle cells through the mediation of growth factors released by endothelial cells. J. Surg. Res. 109 (2003) 16-23
21. Inoue M., Itoh H., Ueda M., Naruko T., Kojima A., Komatsu R., et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98 (1998) 2108-2116
22. Celletti F.L., Waugh J.M., Amabile P.G., Brendolan A., Hilfiker P.R., and Dake M.D. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat. Med. 7 (2001) 425-429
23. Stary H.C., Chandler A.B., and Dinsmore R.E. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92 (1995) 1355-1374
24. Aljada A., Saadeh R., and Assian E. Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J. Clin. Endocrinol. Metab. 85 (2000) 2572-2575
25. Colowick S.P., and Kaplan N.O. Methods for protein determination. Methods in Enzymology vol. 3 (1957), Academic Press, New York 447
26. Takeda A., Perry G., Abraham N.G., Dwyer B.E., Kuttyi R.K., Laitinen J.T., et al. Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau. J. Biol. Chem. 275 (2000) 5395-5399
27. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
28. Abraham N.G., Lutton J.D., and Levere R.D. Heme metabolism and erythropoeisis in abnormal iron states: role of aminolevulinic acid synthetase and heme oxygenase. Exp. Hematol. 13 (1985) 838-843
29. Ishikawa K., Sugawara D., Wang Xp., Suzuki K., Itabe H., Maruyama Y., et al. Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ. Res. 88 (2001) 506-512
30. Chen Y.-X., Nakashima Y., Tanaka K., Shiraishi S., Nakagawa K., and Sueishi K. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 131-139
31. Kuroki M., Voest E.E., and Amano S. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J. Clin. Invest. 98 (1996) 1667-1675
32. Simons M. Angiogenesis: where do we stand now?. Circulation 111 (2005) 1556-1566
33. Duyndam M.C., Hulscher T.M., and Fontijn D. Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite. J. Biol. Chem. 276 (2001) 48066-48076
34. Ramos M.A., Kuzuya M., and Esaki T. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1188-1196
35. Khurana R., Shafi S., Martin J., and Zachary I. Vascular endothelial growth factor gene transfer inhibits neointimal macrophage accumulation in hypercholesterolemic rabbits. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1074-1080
36. Zachary I., Mathur A., Yla-Herttuala S., and Martin J. Vascular protection: a novel nonangiogenic cardiovascular role for vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1512-1520
37. Laitinen M., Zachary I., Breier G., Pakkanen T., Hakkinen T., Luoma J., et al. VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum. Gene Ther. 8 (1997) 1737-1744
38. Abdel-Aziz M.T., El-Asmar M.F., and El-Miligy D. The mechanism of angiogenesis induced by human HO-1 in relation to the expression of cytokines. Int. J. Biochem. Cell Biol. 35 (2003) 324-332
39. Bussolati B., Ahmed A., Pemberton H., Landis R.C., Di Carlo F., Haskard D.O., et al. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 103 (2004) 761-766
40. Jozkowicz A., Huk I., Nigisch A., Weigel G., Dietrich W., Motterlini R., et al. Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX. Antioxid. Redox Signal. 5 (2003) 155-162
41. Deramaudt B.M., Braunstein S., Remy P., and Abraham N.G. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J. Cell. Biochem. 68 (1998) 121-127
42. Soares M.P. VEGF: is it just an inducer of heme oxygenase-1 expression?. Blood 103 (2004) 751